Clinical trial · Interventional
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
Electromagnetic Navigation-Guided Versus CT-Guided Localization of Pulmonary Nodules: A Multicenter, Prospective, Randomized Controlled Trial
NCT07595120CI-TRIAL-00112068not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to design and conduct a multicenter, prospective, randomized controlled post-market clinical trial to validate the clinical efficacy of high-precision electromagnetic navigation technology.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early-Stage Lung Cancer | — | UNRESOLVED | — |
| Pulmonary Nodules | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CT-Guided Percutaneous Localization of Pulmonary Nodules | Procedure | — | UNRESOLVED |
| Electromagnetic Navigation-Guided Percutaneous Localization of Pulmonary Nodules | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Electromagnetic Navigation Localization Group
- interventionNames
- Procedure: Electromagnetic Navigation-Guided Percutaneous Localization of Pulmonary Nodules
- type
- ACTIVE_COMPARATOR
- label
- CT-Guided Localization Group
- interventionNames
- Procedure: CT-Guided Percutaneous Localization of Pulmonary Nodules
Primary outcomes (1)
- measure
- Success rate of intraoperative localization of lung nodules
- timeFrame
- Day 0 (Intraoperative)
- description
- Thoracoscopic exploration enables accurate identification and localization of markers (e.g., contrast dye, microcoils, etc.), with the distance between the center of the marker or the main imaging area and the center of the target nodule being ≤20 mm, and ultimately successfully guides the resection of the target lesion.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age 18-80 years, regardless of gender; 2. Solitary single nodule, scheduled for lung nodule puncture and localization; 3. Chest CT (lung window mode) showing a maximum nodule diameter ≤ 2 cm; 4. Eastern Cooperative Oncology Group (ECOG) performance status score 0-2; 5. Voluntary participation, with signed informed consent. Exclusion Criteria: 1. Not suitable for video-assisted thoracoscopic surgery; 2. The distance between the center of the lesion and the dome of the diaphragm is \< 3 cm; 3. History of thoracic adhesion due to previous thoracotomy or pleural infection; 4. Patients judged by the investigator to be unsuitable for preoperative transthoracic or transbronchial localization; 5. Inability to complete follow-up or poor compliance.
References
Publications (0)
Data not yet available
No reference posted for this study.